Home » Topics » Regulatory

Regulatory
RSS

European Commission approves Zynquista for type 1 diabetes

April 29, 2019

FDA approves intravenous Benlysta for pediatric SLE

April 29, 2019

FDA approves Duobrii for plaque psoriasis

April 26, 2019

FDA approves Skyrizi for moderate to severe plaque psoriasis

April 24, 2019

FDA approves Balversa for metastatic bladder cancer

April 15, 2019

FDA approves Dovato for treatment-naive HIV-1

April 9, 2019

CE mark for radioenhancer Hensify for locally advanced soft tissue sarcoma

April 8, 2019

Asceniv approved by FDA to treat humoral immunodeficiency disease

April 2, 2019

FDA approves Duaklir for maintenance treatment of COPD

April 1, 2019

Cimzia becomes the first and only FDA-approved treatment for nonradiographic axial spondyloarthritis

March 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...